Leonid Timashev Analyst PerformanceVice President, Biotechnology Analyst at Royal Bank Of CanadaLeonid Timashev is a stock analyst at Royal Bank Of Canada focused in the medical sector, covering 28 publicly traded companies. Over the past year, Leonid Timashev has issued 102 stock ratings, including buy and hold recommendations. While full access to Leonid Timashev's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Leonid Timashev's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings122 Last 1 YearsBuy Recommendations87.70% 107 Buy RatingsCompanies Covered28 Unique Companies Ratings Distribution122RatingsDistribution of strong buy, buy, hold, and sell ratings by Leonid Timashev.RatingPercentageCount Strong Buy0.0%0 ratings Buy87.7%107 ratings Hold12.3%15 ratings Sell0.0%0 ratingsOut of 122 total stock ratings issued by Leonid Timashev at Royal Bank Of Canada, the majority (87.7%) have been Buy recommendations, followed by 12.3% Hold.Best & Worst CallsBest Call0000.0%EWTXJun 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%BHVNMar 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ82.1% of companies on NASDAQ23 companiesNYSE14.3% of companies on NYSE4 companiesNYSEAMERICAN3.6% of companies on NYSEAMERICAN1 companyLeonid Timashev, an analyst at Royal Bank Of Canada, currently covers 28 companies listed on NASDAQ, NYSE and NYSEAMERICAN, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical27 companies96.4%Consumer Staples1 company3.6%Leonid Timashev of Royal Bank Of Canada specializes in stock coverage within the Medical sector, with additional focus on Consumer Staples companies.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE21 companies75.0%MED - DRUGS4 companies14.3%MEDICAL SERVICES1 company3.6%CONS PD - MISC STPL1 company3.6%SURGICAL & MEDICAL INSTRUMENTS1 company3.6% Leonid Timashev's Ratings History at Royal Bank Of Canada Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsPRAXPraxis Precision Medicines6/17/2026Initiated Coverage$270.01$449.00Outperform$0.0000.00% ROIEWTXEdgewise Therapeutics6/17/2026Boost Price Target$34.10$59.00Outperform$0.0000.00% ROICYTKCytokinetics6/17/2026Reiterated Rating$75.21$119.00Outperform$0.0000.00% ROIPRAXPraxis Precision Medicines6/17/2026Upgrade$282.31Moderate Buy$0.0000.00% ROIALKSAlkermes6/9/2026Boost Price Target$44.09$56.00Outperform$0.0000.00% ROIINSMInsmed6/5/2026Lower Price Target$104.92$195.00Outperform$0.0000.00% ROIADCTADC Therapeutics6/4/2026Downgrade$3.07$2.00Sector Perform$0.0000.00% ROIEWTXEdgewise Therapeutics6/2/2026Lower Price Target$38.56$48.00Outperform$0.0000.00% ROIRVMDRevolution Medicines6/2/2026Boost Price Target$156.54$182.00Outperform$0.0000.00% ROIONCBeOne Medicines6/2/2026Boost Price Target$279.44$436.00Outperform$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. JSPRJasper Therapeutics5/15/2026Set Price Target$0.82$3.00Sector Perform$0.0000.00% ROICMPSCompass Pathways5/14/2026Boost Price Target$11.02$22.00Outperform$0.0000.00% ROILEGNLegend Biotech5/13/2026Boost Price Target$28.64$64.00Outperform$0.0000.00% ROICGONCG Oncology5/11/2026Boost Price Target$70.52$81.00Outperform$0.0000.00% ROIINSMInsmed5/8/2026Lower Price Target$99.15$205.00Outperform$0.0000.00% ROIRVMDRevolution Medicines5/7/2026Boost Price Target$144.32$165.00Outperform$0.0000.00% ROIONCBeOne Medicines5/7/2026Boost Price Target$314.90$425.00Outperform$0.0000.00% ROICYTKCytokinetics5/6/2026Boost Price Target$75.19$119.00Outperform$0.0000.00% ROIJAZZJazz Pharmaceuticals5/6/2026Boost Price Target$224.32$258.00Outperform$0.0000.00% ROIAXSMAxsome Therapeutics5/5/2026Boost Price Target$228.88$302.00Outperform$0.0000.00% ROIADCTADC Therapeutics5/5/2026Reiterated Rating$3.77$6.00Outperform$0.0000.00% ROIBHVNBiohaven5/5/2026Lower Price Target$9.37$22.00Outperform$0.0000.00% ROINUVBNuvation Bio5/5/2026Reiterated Rating$4.72$20.00Outperform$0.0000.00% ROIBRCCBRC5/5/2026Reiterated Rating$1.30$2.50Buy$0.0000.00% ROICRMDCorMedix4/28/2026Reiterated Rating$7.82$14.00Outperform$0.0000.00% ROICGONCG Oncology4/27/2026Boost Price Target$69.57$79.00Outperform$0.0000.00% ROIIDYAIDEAYA Biosciences4/14/2026Boost Price Target$32.82$53.00Outperform$0.0000.00% ROIINSMInsmed4/14/2026Boost Price Target$151.14$216.00Outperform$0.0000.00% ROIBCYCBicycle Therapeutics3/18/2026Lower Price Target$4.63$7.00Sector Perform$0.0000.00% ROICATXPerspective Therapeutics3/17/2026Lower Price Target$4.88$14.00Outperform$0.0000.00% ROILEGNLegend Biotech3/11/2026Lower Price Target$20.21$62.00Outperform$0.0000.00% ROIDSGNDesign Therapeutics3/10/2026Boost Price Target$10.54$14.00Outperform$0.0000.00% ROINUVBNuvation Bio3/3/2026Boost Price Target$4.53$13.00Outperform$0.0000.00% ROIBHVNBiohaven3/3/2026Boost Price Target$10.87$23.00Outperform$0.0000.00% ROIEXELExelixis3/2/2026Lower Price Target$41.07$43.00Sector Perform$0.0000.00% ROIONCBeOne Medicines2/26/2026Boost Price Target$322.37$425.00Outperform$0.0000.00% ROIALKSAlkermes2/26/2026Lower Price Target$30.33$45.00Outperform$0.0000.00% ROIJAZZJazz Pharmaceuticals2/25/2026Boost Price Target$192.05$195.00Outperform$0.0000.00% ROIAXSMAxsome Therapeutics2/24/2026Boost Price Target$170.33$222.00Outperform$0.0000.00% ROICYTKCytokinetics2/20/2026Boost Price Target$67.66$101.00Outperform$0.0000.00% ROIThe end may be near for these iconic stocks (Ad)Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge. Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks. Stream his free presentation to get every buy and sell recommendation with no membership or credit card required.Watch Marc Chaikin's free presentation and get his full buy-and-sell list todayCMPSCompass Pathways2/18/2026Boost Price Target$7.63$22.00Outperform$0.0000.00% ROIIDYAIDEAYA Biosciences2/18/2026Reiterated Rating$30.75$49.00Outperform$0.0000.00% ROIEXELExelixis2/11/2026Boost Price Target$42.01$46.00Sector Perform$0.0000.00% ROICMPSCompass Pathways1/23/2026Boost Price Target$7.40$21.00Outperform$0.0000.00% ROINUVBNuvation Bio1/21/2026Boost Price Target$6.00$12.00Outperform$0.0000.00% ROINAMSNewAmsterdam Pharma1/21/2026Boost Price Target$32.41$47.00Outperform$0.0000.00% ROIINSMInsmed1/21/2026Boost Price Target$163.51$200.00Outperform$0.0000.00% ROIIDYAIDEAYA Biosciences1/21/2026Boost Price Target$35.75$45.00Outperform$0.0000.00% ROICRMDCorMedix1/21/2026Set Price Target$6.88$13.00Outperform$0.0000.00% ROICGONCG Oncology1/21/2026Boost Price Target$54.69$73.00Outperform$0.0000.00% ROIAXSMAxsome Therapeutics1/21/2026Boost Price Target$184.50$219.00Outperform$0.0000.00% ROICYTKCytokinetics1/21/2026Reiterated Rating$64.68$95.00Outperform$0.0000.00% ROILEGNLegend Biotech1/20/2026Reiterated Rating$23.39$66.00Outperform$0.0000.00% ROICYTKCytokinetics12/22/2025Boost Price Target$62.72$95.00Outperform$0.0000.00% ROIPYXSPyxis Oncology12/18/2025Lower Price Target$1.73$5.00Outperform$0.0000.00% ROIINSMInsmed12/18/2025Lower Price Target$198.46$195.00Outperform$0.0000.00% ROIONCBeOne Medicines12/17/2025Reiterated Rating$307.91Outperform$0.0000.00% ROILEGNLegend Biotech12/8/2025Reiterated Rating$24.54$74.00Outperform$0.0000.00% ROIDSGNDesign Therapeutics11/20/2025Upgrade$7.34$13.00Outperform$0.0000.00% ROIONCBeOne Medicines11/18/2025Boost Price Target$360.68$408.00Outperform$0.0000.00% ROIJAZZJazz Pharmaceuticals11/17/2025Set Price Target$170.34$194.00Outperform$0.0000.00% ROICGONCG Oncology11/17/2025Boost Price Target$41.01$61.00Outperform$0.0000.00% ROILEGNLegend Biotech11/13/2025Lower Price Target$31.39$74.00Outperform$0.0000.00% ROICYTKCytokinetics11/11/2025Boost Price Target$63.66$87.00Outperform$0.0000.00% ROIONCBeOne Medicines11/7/2025Boost Price Target$314.09$395.00Outperform$0.0000.00% ROIEWTXEdgewise Therapeutics11/7/2025Boost Price Target$17.30$50.00Outperform$0.0000.00% ROIDSGNDesign Therapeutics11/6/2025Boost Price Target$6.46$6.00Sector Perform$0.0000.00% ROIBHVNBiohaven11/6/2025Lower Price Target$8.44$9.00Sector Perform$0.0000.00% ROIXNCRXencor11/6/2025Boost Price Target$14.61$19.00Outperform$0.0000.00% ROINAMSNewAmsterdam Pharma11/6/2025Boost Price Target$37.24$44.00Outperform$0.0000.00% ROIJAZZJazz Pharmaceuticals11/6/2025Boost Price Target$133.08$155.00Outperform$0.0000.00% ROINUVBNuvation Bio11/4/2025Boost Price Target$4.78$8.00Outperform$0.0000.00% ROIAXSMAxsome Therapeutics11/4/2025Boost Price Target$132.75$198.00Outperform$0.0000.00% ROIRVMDRevolution Medicines11/3/2025Initiated Coverage$58.84$77.00Outperform$0.0000.00% ROIINSMInsmed10/31/2025Boost Price Target$192.36$215.00Outperform$0.0000.00% ROIBCYCBicycle Therapeutics10/31/2025Reiterated Rating$8.76$11.00Sector Perform$0.0000.00% ROIBCYCBicycle Therapeutics10/31/2025Downgrade$8.07$11.00Sector Perform$0.0000.00% ROIXNCRXencor10/27/2025Boost Price Target$14.05$18.00Outperform$0.0000.00% ROIALKSAlkermes10/22/2025Boost Price Target$31.09$47.00Outperform$0.0000.00% ROIIDYAIDEAYA Biosciences10/21/2025Boost Price Target$30.51$41.00Outperform$0.0000.00% ROIEXELExelixis10/21/2025Reiterated Rating$35.17$45.00Sector Perform$0.0000.00% ROIVSTMVerastem10/20/2025Set Price Target$8.35$13.00Outperform$0.0000.00% ROIALKSAlkermes9/26/2025Upgrade$27.13$44.00Outperform$0.0000.00% ROIIDYAIDEAYA Biosciences9/9/2025Boost Price Target$24.08$38.00Outperform$0.0000.00% ROIJAZZJazz Pharmaceuticals8/28/2025Boost Price Target$124.38$151.00Outperform$0.0000.00% ROIXNCRXencor8/21/2025Lower Price Target$7.38$15.00Outperform$0.0000.00% ROILEGNLegend Biotech8/12/2025Reiterated Rating$37.38$77.00Outperform$0.0000.00% ROIBCYCBicycle Therapeutics8/11/2025Set Price Target$7.57$27.00Outperform$0.0000.00% ROIINSMInsmed8/8/2025Boost Price Target$109.19$120.00Outperform$0.0000.00% ROIEWTXEdgewise Therapeutics8/8/2025Boost Price Target$12.76$49.00Outperform$0.0000.00% ROITrump’s New Currency Reset (Ad)Trump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 is orchestrating what analyst Porter Stansberry calls a total U.S. money reset, bypassing conventional legal channels under the guise of national security. The last time America reset its currency - under Nixon in the 1970s - it created an average of 1,300 new millionaires a day for over 50 years. Stansberry has identified three asset categories connected to Trump's initiative that could surge, plus his single top investment move.Watch the documentary briefing and find out which side you land onVSTMVerastem8/8/2025Boost Price Target$6.79$13.00Outperform$0.0000.00% ROINUVBNuvation Bio8/8/2025Boost Price Target$2.37$7.00Outperform$0.0000.00% ROINAMSNewAmsterdam Pharma8/7/2025Boost Price Target$22.71$39.00Outperform$0.0000.00% ROIONCBeOne Medicines8/7/2025Boost Price Target$296.70$364.00Outperform$0.0000.00% ROIAXSMAxsome Therapeutics8/5/2025Boost Price Target$106.54$189.00Outperform$0.0000.00% ROIALKSAlkermes7/30/2025Boost Price Target$27.11$42.00Sector Perform$0.0000.00% ROIEXELExelixis7/29/2025Lower Price Target$37.20$45.00Sector Perform$0.0000.00% ROIBCYCBicycle Therapeutics7/17/2025Lower Price Target$7.85$25.00Outperform$0.0000.00% ROICGONCG Oncology7/16/2025Lower Price Target$25.36$53.00Outperform$0.0000.00% ROIONCBeOne Medicines7/16/2025Boost Price Target$276.52$349.00Outperform$0.0000.00% ROIIDYAIDEAYA Biosciences7/9/2025Upgrade$21.45$30.00Moderate Buy$0.0000.00% ROIVSTMVerastem6/25/2025Upgrade$4.44$12.00Moderate Buy$0.0000.00% ROICRMDCorMedix6/20/2025Upgrade$13.76$17.00Moderate Buy$0.0000.00% ROIADCTADC Therapeutics6/20/2025Upgrade$3.07$5.00Moderate Buy$0.0000.00% ROINUVBNuvation Bio6/17/2025Upgrade$1.79$6.00Moderate Buy$0.0000.00% ROIAXSMAxsome Therapeutics6/12/2025Lower Price Target$107.04$186.00Outperform$000.0000.00% ROIEWTXEdgewise Therapeutics6/5/2025Reiterated Rating$14.25$48.00Outperform$00.0000.00% ROICATXPerspective Therapeutics6/3/2025Upgrade$3.21$16.00Moderate Buy$0.0000.00% ROIBHVNBiohaven5/19/2025Downgrade$16.07$21.00Sector Perform$0.0000.00% ROIBHVNBiohaven5/13/2025Lower Price Target$19.39$54.00Outperform$0.0000.00% ROIAXSMAxsome Therapeutics4/29/2025Boost Price Target$110.82$193.00Outperform$000.0000.00% ROIEWTXEdgewise Therapeutics4/3/2025Lower Price Target$12.77$52.00Outperform$00.0000.00% ROIPYXSPyxis Oncology3/19/2025Reiterated Rating$1.07$8.00Outperform$0.0000.00% ROIBRCCBRC3/19/2025Reiterated Rating$2.12$3.00Buy$0.0000.00% ROIALKSAlkermes3/13/2025Initiated Coverage$33.41$40.00Sector Perform$00.0000.00% ROIBHVNBiohaven3/4/2025Reiterated Rating$30.42$61.00Outperform$00.0000.00% ROIEWTXEdgewise Therapeutics3/4/2025Reiterated Rating$25.09$56.00Outperform$00.0000.00% ROIINSMInsmed2/25/2025Initiated Coverage$80.03$100.00Outperform$000.0000.00% ROIAXSMAxsome Therapeutics2/19/2025Boost Price Target$127.42$192.00Outperform$000.0000.00% ROINAMSNewAmsterdam Pharma1/24/2025Reiterated Rating$23.67$40.00Outperform$00.0000.00% ROIINCYIncyte1/23/2025Reiterated Rating$72.24$70.00Sector Perform$000.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysMorgan StanleyWells Fargo & CompanyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche Bank AktiengesellschaftStifel Nicolaus Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.